Evidence map›Paper›PMID 36345998›Full record

ArticleJornal brasileiro de nefrologia

Brazilian Dialysis Survey 2021.

Fabiana B Nerbass, Helbert do Nascimento Lima, Fernando Saldanha Thomé, Osvaldo Merege Vieira Neto, Ricardo Sesso, Jocemir Ronaldo Lugon

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Brazilian Dialysis Survey 2022.Jornal brasileiro de nefrologia
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Fabiana B NerbassFundação Pró-Rim, Joinville, SC, Brazil.ORCID 0000-0001-9936-0185
Helbert do Nascimento LimaUniversidade da Região de Joinville, Joinville, SC, Brazil.
Fernando Saldanha ThoméUniversidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.ORCID 0000-0001-5378-3510
Osvaldo Merege Vieira NetoUniversidade de São Paulo, Ribeirão Preto, Brazil.
Ricardo SessoUniversidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-1062-0073
Jocemir Ronaldo LugonUniversidade Federal Fluminense, Niterói, RJ, Brazil.ORCID 0000-0001-6791-3910
Hospital do Rim e Hipertensão · BRUniversidade da Região de Joinville · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Brazilian Dialysis Survey (BDS) is an important source of national data about people on chronic dialysis that contributes to the formulation of health policies regarding kidney failure.

objectiveTo report the 2021 epidemiological data from the BDS of the Brazilian Society of Nephrology (BSN).

methodsA survey was carried out in Brazilian chronic dialysis centers using an online questionnaire covering clinical and epidemiological aspects of patients in chronic dialysis, data on dialysis therapy, characteristics of dialysis centers, and the impact of the COVID-19 pandemic of 2021.

resultsThirty percent (n = 252) of the centers answered the questionnaire. In July 2021, the estimated total number of patients on dialysis was 148,363. The estimated prevalence and incidence rates of patients per million population (pmp) were 696 and 224, respectively. Of the prevalent patients, 94.2% were on hemodialysis (HD) (1.8% of these on hemodiafiltration), and 5.8% on peritoneal dialysis (PD); 21% were on the transplant waiting list. The incidence rate of confirmed COVID-19 between January and July 2021 was 1,236/10,000 dialysis patients, and the case-fatality rate reached 25.5%. Up to July 2021, 88.6% of patients had received at least one dose of the anti-SARS-CoV-2 vaccine. The estimated overall and COVID-19 crude annual mortality rates were 22.3% and 5.3%, respectively.

conclusionThe absolute number and the prevalence rate of patients on chronic dialysis continue to increase. Most dialysis patients were vaccinated against COVID-19 during the year. The COVID-19 pandemic was associated to the overall mortality rate.

Identifiers

PMID36345998
PMCPMC10627134
OpenAlexW4308340707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.